115 Corstorphine Rd, Edinburgh EH12 5PZ, UK

Call us : 0131 337 5100

Travel vaccinations

Meningitis B Vaccination Service

Proactive immunization targeting the primary bacterial strain causing meningitis in the UK at Edinburgh Travel Clinic.
Why Patients Choose Us for Meningitis B Care

5 Star Rated Expert Team

Your care is overseen by GPhC-registered clinicians at our premier Edinburgh Travel Clinic who understand varicella immunity and safety protocols inside and out.

Convenient Location & Open Today

Visit our private clinic suite for a same-day appointment or walk-in appointment when searching for a trusted clinic near me.

Discreet & Efficient

We respect your time. Book today or book now to enjoy a private, professional consultation with zero primary care bottlenecks.

Regulated & Authentic

Every vaccine we supply is 100% authentic, cold-chain compliant, and fully traceable.

Meningitis B Vaccination

Meningitis B Vaccination

Specialised clinical protection against the primary bacterial strain responsible for the majority of invasive meningitis cases in the UK.

Meningitis B is a serious, vaccine-preventable bacterial infection caused by Neisseria meningitidis group B. It is one of the leading causes of bacterial meningitis (inflammation of the protective membranes surrounding the brain and spinal cord) and septicaemia (blood poisoning). The bacteria are naturally carried harmlessly in the back of the nose and throat by many healthy people, but in some individuals, the bacteria can overcome the immune system, invade the bloodstream, and cause rapidly progressive, life-threatening disease.

Primary Transmission Routes

  • Respiratory and Oral Secretions: The bacteria are spread from person to person through close, prolonged contact with respiratory droplets and saliva from the nose and throat of an infected individual or healthy carrier.

  • Close Personal Contact: Transmission typically occurs through activities that involve sharing oral secretions or close physical proximity, such as kissing, coughing, sneezing, sharing drinking cups, bottles, cutlery, or living in crowded communal settings like university halls of residence.

  • Casual Contact Risk: Meningococcal bacteria do not survive long outside the human body, meaning casual contact—such as passing someone in a hallway or sitting next to them briefly—does not typically spread the infection.

Common Symptoms

Meningococcal disease can progress with alarming speed, turning from mild symptoms into a medical emergency within hours. Common signs and symptoms include:

  • Sudden high fever, severe throbbing headache, and a stiff neck.

  • Nausea, vomiting, confusion, extreme lethargy, drowsiness, and sensitivity to bright light (photophobia).

  • A distinctive non-blanching rash (dark purple or red pinprick spots that do not fade when a glass is pressed against them) in cases of blood poisoning (septicaemia).

  • Cold hands and feet, pale or mottled skin, and rapid breathing or severe muscle aches.

Note: Meningitis B requires immediate emergency hospital admission and intravenous antibiotics; delays can lead to permanent brain damage, limb loss, or fatal outcomes.

Prevention and Protection

Because meningitis B can escalate with terrifying speed and devastating consequences, proactive vaccination is the most powerful defense:

  1. Meningitis B Vaccination: Getting the private Meningitis B Vaccine (such as Bexsero) at Murrayfield Pharmacy provides targeted active immunisation against serogroup B strains. It is routinely recommended for infants under the NHS schedule, but private vaccination is widely available for older children, adolescents, university students, and adults seeking comprehensive protection.

  2. Hygienic Practices: Avoid sharing cups, water bottles, utensils, or lip balms, and practice frequent handwashing to reduce exposure to respiratory secretions.

Prevention and Protection

Service Price

Meningitis B Vaccine
ÂŁ130 Per dose
Focused protection providing specific strain defense arrays targeting aggressive meningococcal B variants affecting spinal and cerebral health.
PRICE
ÂŁ 130/ dose
COURSE REQ.
2 doses

Number of Doses Required and When to Boost

  • Primary Course (Age-Dependent):

    • Infants (under 1 year): Typically requires a multi-dose primary series (e.g., 2 or 3 doses) plus a booster in the second year of life.

    • Adolescents and Adults (aged 11 through 50): A primary course consists of two doses administered intramuscularly, with a minimum interval of 1 month between doses.

  • Boosters:

    • Routine booster doses are not routinely recommended for healthy adolescents or adults after completing the initial two-dose primary course, unless they face ongoing, high-risk occupational or clinical exposure.

Number of Doses Required and When to Boost

High-Risk Areas for Meningitis B

Meningitis B occurs globally rather than being confined to specific tropical regions or travel zones:

  • Global Distribution: It is the predominant strain causing meningococcal disease across Europe, the Americas, Australia, and parts of New Zealand.

  • High-Density Settings: Outbreaks or clustered cases are most frequently associated with closed communal environments where young people congregate in close quarters, such as university halls of residence, colleges, and military training camps.

Frequently Asked Questions

Who is most at risk for Meningitis B, and who should consider getting vaccinated privately?
Infants, teenagers, and university students entering group housing environments face higher exposure risks, making private catch-up vaccination a powerful preventive choice.
How many doses of the Meningitis B vaccine do older teens and adults require?
Adolescents and adults generally require a two-dose course administered with a minimum interval of one month between injections.
Can the Meningitis B vaccine be given at the same time as other travel or seasonal vaccines?
Yes, though our clinicians may space injections or administer them in separate injection sites to monitor and manage normal post-vaccination reactions comfortably.
What does the Meningitis B vaccine protect against?
The Meningitis B vaccine (such as Bexsero) protects specifically against invasive disease caused by Neisseria meningitidis group B bacteria. Group B is the leading cause of bacterial meningitis and sepsis (blood poisoning) in infants, children, and young adults in many parts of the world.
Who is eligible for the Meningitis B vaccine?
Infants and Children: Routinely offered as part of the UK childhood immunization schedule starting at 8 weeks of age.Teens and Young Adults: Highly recommended for university and college students living in close quarters (such as student halls), where the risk of spreading the bacteria is elevated.Travellers and High-Risk Individuals: Recommended for travellers visiting regions with high endemic rates of meningococcal disease, individuals with certain underlying health conditions (like asplenia), or laboratory workers handling the bacteria.
How is the vaccine administered and how many doses are needed?
Administration: Given as an injection into the muscle (into the thigh for infants or the upper arm for older children and adults).Dose Schedule: The number of doses required depends entirely on the age at which vaccination begins:Infants (started at 2 months): Usually a primary course of two doses given a couple of months apart, followed by a booster dose around 1 year of age.Older Children and Adults (aged 2 years and older): Requires a primary course of two doses administered at least 1 month apart to ensure strong protection.
What are the common side effects of the vaccine?
Side effects are generally mild, though temporary fever is notably common in young infants:Fever: Particularly in babies under 1 year old, a temporary fever is very common after the injection. (Prophylactic paracetamol is typically recommended for infants following their doses).Local Reactions: Soreness, redness, swelling, or a small tender lump at the injection site.General Symptoms: Irritability, drowsiness, crying, decreased appetite, or a mild headache in older individuals.
Are booster doses required?
For individuals who completed their primary course during infancy, a booster dose is typically given in the second year of life. For older children, adolescents, and adults who received a two-dose primary series, routine booster doses are not universally required, though boosters may be recommended for individuals with ongoing, long-term occupational or medical risks.

Book Now

Loading...

Ready for Your Next Adventure?

Don’t leave your health to chance. Secure your peace of mind and get ready to enjoy your trip to the fullest.
×